← Mechanisms of action
FCGR1A
SINGLE PROTEINHomo sapiens
Preferred name: High affinity immunoglobulin gamma Fc receptor I ChEMBL ↗
Linked proteins
Drugs acting on this target (16)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| iph6501 | Activator | experimental | mAb | FCGR1A activator |
| scp776 | Agonist | experimental | Recombinant protein | FCGR1A agonist |
| H22xKi-4 | Antagonist | experimental | mAb | FCGR1A antagonist |
| MDX-240 | Binding agent | experimental | mAb | FCGR1A binding agent |
| MDX-H210 | Binding agent | experimental | mAb | FCGR1A binding agent |
| catumaxomab (Removab) | Cross-linking agent | experimental | mAb | FCGR1A cross-linking agent |
| mdx-210 | Cross-linking agent | experimental | mAb | High affinity immunoglobulin gamma Fc receptor I cross-linking agent |
| mdx447 | Cross-linking agent | experimental | mAb | High affinity immunoglobulin gamma Fc receptor I cross-linking agent |
| cd64 car t cells | Immunity, passive | experimental | Cell therapy | FCGR1A immunity, passive |
| 4g7xh22 | Inhibitor | experimental | mAb | FCGR1A inhibitor |
| mdx-033 | Inhibitor | experimental | mAb | FCGR1A inhibitor |
| mdx-210 | Inhibitor | experimental | mAb | FCGR1A inhibitor |
| mdx-220 | Inhibitor | experimental | mAb | FCGR1A inhibitor |
| mdx447 | Inhibitor | experimental | mAb | FCGR1A inhibitor |
| mdx-210 | Other | experimental | mAb | FCGR1A other |
| mdx447 | Other | experimental | mAb | FCGR1A other |